Treatment of Atopic bronchitis,atopic rhinitis and atopic dermatitis

An open labelled RCT study to assess the efficacy of virechanottara shleshmakalanala rasa and ashwagandha ghana vati with agnimanthadi kashaya anupana in atopic triad on spirometric values and ige levels - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/09/073732

Enrollment

Registered

2024-09-10

Start date

Unknown

Completion date

Unknown

Last updated

2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J454- Moderate persistent asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Patients with atopic triad Patients fit for rasarasayana purva karma and virechana patients age between 18 to 70 years patients who signed infromed consent

Exclusion criteria

Exclusion criteria: patients having systemic diseases like respiratory failure lung cancer IHD sepsis patients with TB pulmonary embolism fibrosis of lungs traumatic history cardiac asthma pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
changes in Ige AEC and Spirometric values relief from subjective parametersTimepoint: 9 weeks 0 days	—

Secondary

Measure	Time frame
Dismissal of steriod dependance prevention from added respiratory infectionTimepoint: 9 weeks 0 days	—

Countries

India

Contacts

Public ContactDr Sumayya Begum

Taranath Government Ayurveda Medical College and Hospital

drfareedabegumshaikh@gmail.com9886478611

Outcome results